Shenzhen Mindray Bio-Medical Electronics , Ltd. EBIT

The latest EBIT for 300760.SZ is $9.5B as of September 2026. That compares with $9B in the prior-year period — up 5.9% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Shenzhen Mindray Bio-Medical Electronics , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 300760.SZ's EBIT moved from $9B to $9.5B — a 5.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shenzhen Mindray Bio-Medical Electronics , Ltd.'s operating scale or balance-sheet position.

Against its sector companies, 300760.SZ currently prints $9.5B for EBIT, while the sector average sits near $2.6T. That is roughly 99.6% below the sector mean. Large gaps often invite a closer look at Shenzhen Mindray Bio-Medical Electronics , Ltd.'s growth, margins, and balance sheet.

A EBIT figure of $9.5B for 300760.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 300760.SZ's EBIT ($9.5B), review year-over-year change from $9B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.